NDC11 61755001401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 61755-0014-01 | 61755-0014 |
| 61755-0014-1 | 61755-0014 |
| 61755-014-01 | 61755-014 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VEOPOZ | POZELIMAB | Regeneron Pharmaceuticals, Inc. | a8d6f10e-9430-450a-a3dd-b538f9b2a308 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 61755-014-01 61755-014 61755001401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.